Pernix Therapeutics Holdings, Inc.
|
(Name of Issuer) |
Common Stock, $0.01 par value
|
(Title of Class of Securities) |
71426V108
|
(CUSIP Number) |
Brandon R. Belanger
33219 Forest West Drive
Magnolia, TX 77354
(832) 934-1825
|
(Name, address and telephone number of person authorized to receive notices and communications)
|
November 4, 2013
|
(Date of event which requires filing of this statement) |
CUSIP No. 71426V108 | SCHEDULE 13D | Page 2 of 4 Pages |
(1)
|
Names of Reporting Persons
Brandon R. Belanger
|
|||
(2)
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) þ
|
|||
(3)
|
SEC Use Only
|
|||
(4)
|
Source of Funds (See Instructions)
N/A
|
|||
(5)
|
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
N/A
|
|||
(6)
|
Citizenship or Place of Organization
United States
|
|||
Number of Shares
|
(7)
|
Sole Voting Power
1,614,238 (see Item 5)
|
|
|
Beneficially
|
(8)
|
Shared Voting Power
0
|
|
|
Owned by Each
|
(9)
|
Sole Dispositive Power
1,614,238 (see Item 5)
|
|
|
Reporting Person
with
|
(10)
|
Shared Dispositive Power
0
|
|
|
(11)
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,614,238 (see Item 5)
|
|||
(12)
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
N/A
|
|||
(13)
|
Percent of Class Represented by Amount in Row (11)
4.34%(1)
|
|||
(14)
|
Type of Reporting Person (See Instructions)
IN
|
CUSIP No. 71426V108 | SCHEDULE 13D | Page 3 of 4 Pages |
Item 1.
|
Security and Issuer.
|
Item 2.
|
Identity and Background.
|
Item 3.
|
Source or Amount of Funds or Other Consideration.
|
Item 4.
|
Purpose of the Transaction.
|
Item 5.
|
Interest in Securities of the Issuer.
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
|
Item 7.
|
Material to be filed as Exhibits.
|
CUSIP No. 71426V108 | SCHEDULE 13D | Page 4 of 4 Pages |
January 13, 2014
|
/s/ Brandon R. Belanger
|
|||
Date
|
Signature
|